Abivax 2024 Financial Communication Calendar

Abivax 2024 Financial Communication Calendar PARIS, France, January 4, 2024, 8:30 a.m. CET – Abivax SA ((Euronext Paris &amp, NASDAQ:ABVX) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, today publishes its 2024 financial communication calendar. Tuesday, April 2, 20242023 Annual Business and Financial Report (as of Decemb ...